Skip to main content
Back to News

News From Around the System

Giving Immunotherapy Cells Resilience to Pass the ‘Stress Test’

UCSF Health — August 23, 2022

T cells used in immunotherapy treatments can get exhausted and shut down by fighting cancer cells and tumors. Using a CRISPR-based edit on these cells’ genomes, researchers at UCSF and Gladstone Institutes have rendered the therapeutic cells more resilient against tumors.

Beware of cannabis brownies, candies and other treats that appeal to kids

UC Davis Health — August 23, 2022

They may look like familiar supermarket treats like gummy bears, brownies and cookies. But make no mistake: Edible cannabis products are not for kids. Unfortunately, many kids end up in emergency rooms after mistakenly eating one of these products when they find them at home.

Edible cannabis brownies, gummy bears and candies

Who should – and who shouldn’t – take daily aspirin

UC Davis Health — August 22, 2022

For decades aspirin has been used to prevent repeat heart attack and stroke, and prevent the initial occurrence of these events in high-risk people. Based on new research, the USPSTF has updated its recommendations on the use of aspirin for prevention of cardiovascular disease.

Hand holding two pills and glass of water

Surgery resident awarded prestigious T32 federal research grant

UC Davis Health — August 22, 2022

Cardiothoracic surgery resident Nataliya Bahatyrevich has become the latest UC Davis trainee to receive a prestigious T32 federal research grant. The award will allow her to spend a year in the laboratory and pursue a Master of Science in biomedical engineering at UC Davis

Portrait of Nataliya Bahatyrevich, a cardiothoracic surgery resident who has been awarded a T32 federal research grant

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts